Cellarity signs up with Excelra for GOSTAR database to enrich its drug discovery platform

Food and Healthcare Press Releases Thursday November 5, 2020 10:10
HYDERABAD India and CAMBRIDGE Mass.--5 Nov--PRNewswire/InfoQuest

Excelra, a leading global data science & data analytics company, and Cellarity, a flagship pioneering company working on the development of a new generation of medicines to treat diseases at the level of cell behaviours, have today announced an agreement whereby Excelra will provide Cellarity access to its Global Online Structure Activity Relationship database (GOSTAR).

GOSTAR is the world's largest small molecule medicinal chemistry intelligence platform that encompasses over 8 million compounds, linking chemical structure to biological, pharmacological and therapeutic activities. With a vast knowledge base of 28 million SAR data points, GOSTAR equips researchers in the early as well as optimization stages of drug discovery.

Cellarity's drug discovery platform uses high-resolution biological data and unique machine learning capabilities to pioneer an entirely new approach to drug discovery. Cellarity is designing medicines that target and change cell behaviors to unlock treatments in a large number of disease areas. "We are looking forward to using high quality annotated GOSTAR data on millions of small molecules, while leveraging Cellarity's proprietary AI/ML modules to generate predictable drug-like molecules that ultimately guide the design of novel Cell Behavior-Targeted therapies. Our preliminary assessment gives us the confidence in the utility of GOSTAR database," said Ramakanth Sarabu, Head of Chemistry, Cellarity.

"GOSTAR is a widely used structure activity relationship database in AI/ML driven drug discovery programs. We strongly believe that this collaboration equips AI/ML and medicinal chemistry researchers at Cellarity to utilize curated interactions of millions of small molecules with potential drug targets to generate novel compounds with desired pharmacological profiles," said Raveendra Dayam, Director, Chemistry Services, Excelra.

About Cellarity:

Cellarity is a first-of-its-kind therapeutics company that is discovering and developing medicines by studying and altering cell behaviors. Cellarity has developed a powerful, generalizable platform harnessing single-cell technologies, machine learning and proprietary data models of disease to unveil the network state of a given cell. The platform digitizes and quantifies cellular behaviors, unravels the network dynamics that govern those behaviors, and generates medicines that can direct them. https://cellarity.com/

About Excelra:

Excelra's data science and data analytics solutions empower innovation in life sciences. The Excelra Edge comes from a seamless amalgamation of proprietary data assets, domain expertise and data science to accelerate drug discovery & development. Visit www.excelra.com

Dorothy Paul- Director Marketing
Logo: https://mma.prnewswire.com/media/692189/Excelra_Logo.jpg

Latest Press Release

MIM Software Inc. ประกาศความร่วมมือกับ Peter MacCallum Cancer Centre เพื่อปรับปรุงการจัดการผู้ป่วย

MIM Software Inc. บริษัทชั้นนำระดับโลกผู้ให้บริการซอฟต์แวร์การถ่ายภาพทางการแพทย์ ประกาศความร่วมมือกับโรงพยาบาล Peter MacCallum Cancer Centre (Peter Mac) ผ่านทางโปรแกรม Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) Peter Mac และ...

Thailand EEPO 2020: The road to digitalize the Thai public healthcare system

The public healthcare system in Thailand had witnessed many meaningful advancements, thanks to the improvement of technologies and medical innovations. This vast improvement owed a great deal to the cooperation between various stakeholders, who have...

MIM Software Inc. Announces Collaboration with Peter MacCallum Cancer Centre to Improve Patient Management

MIM Software Inc., a leading global provider of medical imaging software, announced today a collaboration with Peter MacCallum Cancer Centre (Peter Mac) in support of its Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC)...

Global leaders welcome the Sanitation and Hygiene Fund as key to increasing investment

The Sanitation and Hygiene Fund will be critical to dramatically scale up investments to reach everyone with sanitation services, United Nations Deputy Secretary-General has said as the new financial mechanism to drive billions of dollars into the...

Takara Belmont Discovers Changes at Core of Hair Structure; Resulting "Hair Medulla Care" Technology Will Change Future of Haircare

Takara Belmont Corporation (hereinafter Takara Belmont) has developed a new technology for analyzing hair, leading to the discovery of structural changes in the medulla, the central part of hair previously largely not visible to researchers. As a result,...

Related Topics